Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Scleroderma Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Scleroderma Therapeuticsmarket, defines the market attractiveness level of Scleroderma Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Scleroderma Therapeutics industry, describes the types of Scleroderma Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Scleroderma Therapeutics market and the development prospects and opportunities of Scleroderma Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Scleroderma Therapeutics market in Chapter 13.
By Player:
Argentis Pharmaceuticals, LLC
Bristol-Myers Squibb Company
Fibrocell Science Inc
F Hoffmann-La Roche AG
Akashi Therapeutics
Prometic Life Sciences Inc
Genkyotex
Boehringer Ingelheim International GmbH
Seattle Genetics Inc
Chemomab
Bayer AG
Emerald Health Pharmaceuticals
Corbus Pharmaceuticals Holdings Inc
Kadmon Holdings Inc
Celgene Corporation
Cytori Therapeutics Inc
By Type:
Immunosuppressors
Phosphodiesterase 5 Inhibitors - PHA
Endothelin Receptor Antagonists
Prostacyclin Analogues
Calcium Channel Blockers
Analgesics
Others
By End-User:
Systemic
Localized
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Scleroderma Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Scleroderma Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Scleroderma Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Scleroderma Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Scleroderma Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Scleroderma Therapeutics Consumption (2017-2022)
-
7.2 United States Scleroderma Therapeutics Consumption (2017-2022)
-
7.3 Europe Scleroderma Therapeutics Consumption (2017-2022)
-
7.4 China Scleroderma Therapeutics Consumption (2017-2022)
-
7.5 Japan Scleroderma Therapeutics Consumption (2017-2022)
-
7.6 India Scleroderma Therapeutics Consumption (2017-2022)
-
7.7 South Korea Scleroderma Therapeutics Consumption (2017-2022)
8 Region and Country-wise Scleroderma Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Scleroderma Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Scleroderma Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Scleroderma Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Scleroderma Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Scleroderma Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Scleroderma Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Scleroderma Therapeutics Consumption Forecast (2022-2028)
9 Global Scleroderma Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Scleroderma Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunosuppressors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Phosphodiesterase 5 Inhibitors - PHA Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Endothelin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Prostacyclin Analogues Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Analgesics Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Scleroderma Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Systemic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Localized Consumption and Growth Rate (2017-2022)
10 Global Scleroderma Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Scleroderma Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunosuppressors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Phosphodiesterase 5 Inhibitors - PHA Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Endothelin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Prostacyclin Analogues Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Scleroderma Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Systemic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Localized Consumption Forecast and Growth Rate (2022-2028)
11 Global Scleroderma Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Scleroderma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Scleroderma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Scleroderma Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Scleroderma Therapeutics Market Competitive Analysis
-
14.1 Argentis Pharmaceuticals, LLC
-
14.1.1 Argentis Pharmaceuticals, LLC Company Details
-
14.1.2 Argentis Pharmaceuticals, LLC Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Argentis Pharmaceuticals, LLC Scleroderma Therapeutics Product and Service
-
14.2 Bristol-Myers Squibb Company
-
14.2.1 Bristol-Myers Squibb Company Company Details
-
14.2.2 Bristol-Myers Squibb Company Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Company Scleroderma Therapeutics Product and Service
-
14.3 Fibrocell Science Inc
-
14.3.1 Fibrocell Science Inc Company Details
-
14.3.2 Fibrocell Science Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Fibrocell Science Inc Scleroderma Therapeutics Product and Service
-
14.4 F Hoffmann-La Roche AG
-
14.4.1 F Hoffmann-La Roche AG Company Details
-
14.4.2 F Hoffmann-La Roche AG Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 F Hoffmann-La Roche AG Scleroderma Therapeutics Product and Service
-
14.5 Akashi Therapeutics
-
14.5.1 Akashi Therapeutics Company Details
-
14.5.2 Akashi Therapeutics Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Akashi Therapeutics Scleroderma Therapeutics Product and Service
-
14.6 Prometic Life Sciences Inc
-
14.6.1 Prometic Life Sciences Inc Company Details
-
14.6.2 Prometic Life Sciences Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Prometic Life Sciences Inc Scleroderma Therapeutics Product and Service
-
14.7 Genkyotex
-
14.7.1 Genkyotex Company Details
-
14.7.2 Genkyotex Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Genkyotex Scleroderma Therapeutics Product and Service
-
14.8 Boehringer Ingelheim International GmbH
-
14.8.1 Boehringer Ingelheim International GmbH Company Details
-
14.8.2 Boehringer Ingelheim International GmbH Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Boehringer Ingelheim International GmbH Scleroderma Therapeutics Product and Service
-
14.9 Seattle Genetics Inc
-
14.9.1 Seattle Genetics Inc Company Details
-
14.9.2 Seattle Genetics Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Seattle Genetics Inc Scleroderma Therapeutics Product and Service
-
14.10 Chemomab
-
14.10.1 Chemomab Company Details
-
14.10.2 Chemomab Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Chemomab Scleroderma Therapeutics Product and Service
-
14.11 Bayer AG
-
14.11.1 Bayer AG Company Details
-
14.11.2 Bayer AG Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bayer AG Scleroderma Therapeutics Product and Service
-
14.12 Emerald Health Pharmaceuticals
-
14.12.1 Emerald Health Pharmaceuticals Company Details
-
14.12.2 Emerald Health Pharmaceuticals Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Emerald Health Pharmaceuticals Scleroderma Therapeutics Product and Service
-
14.13 Corbus Pharmaceuticals Holdings Inc
-
14.13.1 Corbus Pharmaceuticals Holdings Inc Company Details
-
14.13.2 Corbus Pharmaceuticals Holdings Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Corbus Pharmaceuticals Holdings Inc Scleroderma Therapeutics Product and Service
-
14.14 Kadmon Holdings Inc
-
14.14.1 Kadmon Holdings Inc Company Details
-
14.14.2 Kadmon Holdings Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Kadmon Holdings Inc Scleroderma Therapeutics Product and Service
-
14.15 Celgene Corporation
-
14.15.1 Celgene Corporation Company Details
-
14.15.2 Celgene Corporation Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Celgene Corporation Scleroderma Therapeutics Product and Service
-
14.16 Cytori Therapeutics Inc
-
14.16.1 Cytori Therapeutics Inc Company Details
-
14.16.2 Cytori Therapeutics Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Cytori Therapeutics Inc Scleroderma Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Scleroderma Therapeutics
-
Figure Scleroderma Therapeutics Picture
-
Table Global Scleroderma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Scleroderma Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Scleroderma Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Scleroderma Therapeutics Consumption by Country (2017-2022)
-
Figure United States Scleroderma Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Scleroderma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Scleroderma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Scleroderma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Scleroderma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Scleroderma Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Scleroderma Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Scleroderma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Scleroderma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Scleroderma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Scleroderma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Scleroderma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Scleroderma Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunosuppressors Consumption and Growth Rate (2017-2022)
-
Figure Global Phosphodiesterase 5 Inhibitors - PHA Consumption and Growth Rate (2017-2022)
-
Figure Global Endothelin Receptor Antagonists Consumption and Growth Rate (2017-2022)
-
Figure Global Prostacyclin Analogues Consumption and Growth Rate (2017-2022)
-
Figure Global Calcium Channel Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Systemic Consumption and Growth Rate (2017-2022)
-
Figure Global Localized Consumption and Growth Rate (2017-2022)
-
Figure Global Immunosuppressors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Phosphodiesterase 5 Inhibitors - PHA Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Endothelin Receptor Antagonists Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostacyclin Analogues Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Calcium Channel Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Systemic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Localized Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Scleroderma Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Scleroderma Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Argentis Pharmaceuticals, LLC (Foundation Year, Company Profile and etc.)
-
Table Argentis Pharmaceuticals, LLC Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Argentis Pharmaceuticals, LLC Scleroderma Therapeutics Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Scleroderma Therapeutics Product and Service
-
Table Fibrocell Science Inc (Foundation Year, Company Profile and etc.)
-
Table Fibrocell Science Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Fibrocell Science Inc Scleroderma Therapeutics Product and Service
-
Table F Hoffmann-La Roche AG (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche AG Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche AG Scleroderma Therapeutics Product and Service
-
Table Akashi Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Akashi Therapeutics Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akashi Therapeutics Scleroderma Therapeutics Product and Service
-
Table Prometic Life Sciences Inc (Foundation Year, Company Profile and etc.)
-
Table Prometic Life Sciences Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometic Life Sciences Inc Scleroderma Therapeutics Product and Service
-
Table Genkyotex (Foundation Year, Company Profile and etc.)
-
Table Genkyotex Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genkyotex Scleroderma Therapeutics Product and Service
-
Table Boehringer Ingelheim International GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim International GmbH Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim International GmbH Scleroderma Therapeutics Product and Service
-
Table Seattle Genetics Inc (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Inc Scleroderma Therapeutics Product and Service
-
Table Chemomab (Foundation Year, Company Profile and etc.)
-
Table Chemomab Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chemomab Scleroderma Therapeutics Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Scleroderma Therapeutics Product and Service
-
Table Emerald Health Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Emerald Health Pharmaceuticals Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emerald Health Pharmaceuticals Scleroderma Therapeutics Product and Service
-
Table Corbus Pharmaceuticals Holdings Inc (Foundation Year, Company Profile and etc.)
-
Table Corbus Pharmaceuticals Holdings Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Corbus Pharmaceuticals Holdings Inc Scleroderma Therapeutics Product and Service
-
Table Kadmon Holdings Inc (Foundation Year, Company Profile and etc.)
-
Table Kadmon Holdings Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kadmon Holdings Inc Scleroderma Therapeutics Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Scleroderma Therapeutics Product and Service
-
Table Cytori Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Cytori Therapeutics Inc Scleroderma Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cytori Therapeutics Inc Scleroderma Therapeutics Product and Service
-
